BGM0504
A Study of BGM0504 Injection in Participants With Obesity or Overweight
BrightGene Bio-Medical Technology Co · Phase 3 · Completed · Enrollment 652
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| 5 mg BGM0504 injection | n/r | n/r | n/r | n/r | n/r |
| 10 mg BGM0504 injection | n/r | n/r | n/r | n/r | n/r |
| 15 mg BGM0504 injection | n/r | n/r | n/r | n/r | n/r |
| BGM0504 placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.